Free tool
Drug Trial Radar: Pain and anesthesia
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
261
Completed, industry sponsors, Pain and anesthesia, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed261
261 trials
Showing 1 to 25, recently updated first.
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT06887959 · 47 participants · Start Mar 27, 2025 · Primary completion Oct 27, 2025
Drug: Suzetrigine · For: Acute Pain
Sites: Scottsdale, Arizona; Little Rock, Arkansas; Sarasota, Florida · 17 sites in all
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT06887972 · 100 participants · Start Mar 21, 2025 · Primary completion Oct 24, 2025
Drug: Suzetrigine · For: Acute Pain
Sites: Atlanta, Georgia; Boston, Massachusetts; Bellaire, Texas · 5 sites in all
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT07538570 · 66 participants · Start Apr 24, 2026 · Primary completion Oct 12, 2026
Drug: Suzetrigine; Placebo · For: Pain
Sites: Bellaire, Texas; Houston, Texas
Heron TherapeuticsIndustry
NCT03705065 · 30 participants · Start Sep 19, 2018 · Primary completion Oct 8, 2018
Drug: Bupivacaine HCl · For: Postoperative Pain
Sites: Houston, Texas
Heron TherapeuticsIndustry
NCT06109428 · 37 participants · Start Oct 12, 2021 · Primary completion Mar 29, 2022
Drug: MMA regimen; HTX-011 and 1 more · For: Postoperative Pain; Abdominoplasty Surgery; Multimodal Analgesia
Sites: Bellaire, Texas; San Antonio, Texas
Heron TherapeuticsIndustry
NCT06109415 · 30 participants · Start Oct 20, 2021 · Primary completion Jul 18, 2022
Drug: HTX-011; Bupivacaine Hydrochloride and 1 more · For: Postoperative Pain; Total Shoulder Arthroplasty; Multimodal Analgesia
Sites: Little Rock, Arkansas; Jenks, Oklahoma; Bellaire, Texas · 5 sites in all
- Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPSPivotal-lookingCompleted
Xintian PharmaceuticalIndustry
NCT06159114 · 242 participants · Start Dec 19, 2023 · Primary completion Jan 31, 2025
Drug: Ningmitai capsule; Celecoxib capsule and 2 more · For: Chronic Prostatitis
Sites: Fuzhou, China
Janssen-Cilag Ltd.Johnson & Johnson (Janssen) (JNJ)
NCT00771199 · 14 participants · Start Oct 1, 2008 · Primary completion Nov 26, 2008
Drug: Transdermal Therapeutic System (TTS)-Fentanyl · For: Cancer, Pain
Sites: High Wycombe, United Kingdom
- Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive MedicationsPivotal-lookingCompleted
PfizerPfizer (PFE)
NCT05518123 · 962 participants · Start Nov 7, 2022 · Primary completion Mar 31, 2025
Drug: Rimegepant; Placebo · For: Migraine
Sites: Los Angeles, California; Sherman Oaks, California; Stamford, Connecticut · 111 sites in all
- Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan UsePivotal-lookingCompleted
PfizerPfizer (PFE)
NCT05509400 · 813 participants · Start Oct 18, 2022 · Primary completion Mar 10, 2025
Drug: Rimegepant; Placebo and 1 more · For: Migraine
Sites: Los Angeles, California; Stamford, Connecticut; Lake City, Florida · 93 sites in all
- Efficacy of Intra-articular Collagen Injection in Patients With Knee Joint Pain Compared to Normal Saline InjectionPivotal-lookingCompleted
Cellontech Co., Ltd.Industry
NCT02539095 · 200 participants · Start Apr 2014 · Primary completion Aug 2015
Drug: Normal saline · For: Chondromalacia; Osteoarthritis; Traumatic Arthritis
Sites: Seoul, South Korea · 5 sites in all
- Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With HypercholesterolemiaPivotal-lookingCompleted
Novartis PharmaceuticalsNovartis (NVS)
NCT05192941 · 1,770 participants · Start Apr 8, 2022 · Primary completion Jun 11, 2024
Drug: Inclisiran Sodium; Placebo · For: Hypercholesterolemia
Sites: Sofia, Bulgaria; Burgas, Bulgaria; Gabrovo, Bulgaria · 136 sites in all
HALEONIndustry
NCT06379893 · 196 participants · Start Apr 25, 2024 · Primary completion Oct 29, 2024
Drug: Voltaren Gel · For: Pain
Sites: Marrero, Louisiana; San Antonio, Texas; Bydgoszcz, Poland · 8 sites in all
Tanabe Pharma GmbHIndustry
NCT05740371 · 50 participants · Start Apr 18, 2017 · Primary completion May 6, 2021
Drug: Argatroban · For: Stable Coronary Artery Disease (CAD); Unstable Angina (Troponin Negative)
Sites: Frankfurt am Main, Germany; Rotenburg an der Fulda, Germany
- Study of the Efficacy of Kalinox® 170 Bar in Adult OncologyPivotal-lookingCompleted
Air Liquide Santé InternationalIndustry
NCT00646945 · 204 participants · Start Sep 2007 · Primary completion Oct 2008
Drug: 50% Oxygen/50% Nitrous oxide premix (Kalinox 170 bar); 50% Oxygen/50% Nitrogen premix · For: Cancer; Pain
Sites: Vandœuvre-lès-Nancy, France
- The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-IodinePivotal-lookingCompleted
Harrow IncIndustry
NCT05934253 · 100 participants · Start Jul 15, 2023 · Primary completion Jan 15, 2024
Drug: Chloroprocaine ophthalmic gel 3% · For: Antiseptic; Anesthesia, Local
Sites: Brandon, Florida
Air Liquide Santé InternationalIndustry
NCT00937807 · 84 participants · Start Jul 2009 · Primary completion Feb 2010
Drug: xenon; sévoflurane · For: Hemodynamic Stability
Sites: Paris, France
- OpiCapone Effect on Motor Fluctuations and pAiNPivotal-lookingCompleted
Bial - Portela C S.A.Industry
NCT04986982 · 144 participants · Start Feb 25, 2021 · Primary completion Feb 16, 2024
Drug: Opicapone 50 mg · For: Parkinson Disease
Sites: London, United Kingdom
- Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back PainPivotal-lookingCompleted
Menarini International Operations Luxembourg SAIndustry
NCT05170841 · 538 participants · Start Sep 17, 2020 · Primary completion May 4, 2022
Drug: Dexketoprofen Trometamol 25 mg/Tramadol Hydrochloride 75 mg; Tramadol Hydrochloride 100 mg and 1 more · For: Low Back Pain
Sites: L’Aquila, Italy
RDC Clinical Pty LtdIndustry
NCT06351917 · 80 participants · Start Apr 24, 2024 · Primary completion Jun 18, 2024
Drug: PlexoZome® Levagen® topical spray solution; Placebo topical spray solution · For: Knee Joint Pain
Sites: Brisbane, Australia
RDC Clinical Pty LtdIndustry
NCT05810116 · 80 participants · Start May 19, 2023 · Primary completion Dec 20, 2023
Drug: Levagen+; Microcrystalline cellulose · For: Menstrual Pain
Sites: New Farm, Australia
- Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour AnalgesiaPivotal-lookingCompleted
Hamad Medical CorporationIndustry
NCT06266767 · 136 participants · Start Feb 21, 2024 · Primary completion Oct 5, 2024
Drug: Levobupivacaine and Fentanyl · For: Labor Pain; Obstetric Pain; Analgesia
Sites: Doha, Qatar
- Osteoarthritis Knee Pain Relief Study of 0.25% 920-CGS-200Pivotal-lookingCompleted
Propella TherapeuticsIndustry
NCT03124407 · 120 participants · Start Jul 2016 · Primary completion Oct 2016
Drug: Capsaicin Topical Solution · For: Osteoarthritis, Knee
Sites: Clearwater, Florida; Tampa, Florida; Dallas, Texas
Novartis PharmaceuticalsNovartis (NVS)
NCT04084314 · 701 participants · Start Sep 30, 2019 · Primary completion Feb 23, 2023
Drug: Erenumab · For: Migraine; Migraine Disorders; Migraine Headache
Sites: Stuttgart, Germany; Marburg Wehrda, Germany; Hanover, Germany · 75 sites in all
Organon and CoIndustry
NCT00380627 · 337 participants · Start Sep 1, 2005 · Primary completion Jan 31, 2006
Drug: MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days · For: Pain
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.